Individuals who are employed by a company that has a real or potential financial interest in the outcome of the Cochrane Review (including but not limited to drug companies or medical device manufacturers), or who hold or have applied for a patent related to the Cochrane Review are prohibited from being Cochrane Review authors. In most cases, employment would be characterised by the affiliation statement made by the author at the title registration, protocol, or review stage of the Cochrane Review. Any questions about what constitutes by a “employment company with a financial interest” should be referred to the Funding Arbiter. Authors who in the last three years have received financial support from commercial sponsors or sources who have a real or potential financial interest in the findings of the Cochrane Review, but who are not covered by the restriction above may need review by the Funding Arbiter panel. Such financial support may include remuneration from a consultancy, grants, fees, fellowships, support for sabbaticals, royalties, stocks from pharmaceutical companies, advisory board membership, or otherwise. In such cases, at the Funding Arbiter’s discretion, and only where a majority of the review authors and lead author have no relevant conflicts of interests, it may be possible for an author who has a declared interest as listed in the previous sentence to be a Cochrane Review author. Authors should declare potential conflicts even if they are confident that their judgement is not influenced (see ). Do you or your co-authors have any interests in this that could be perceived as conflicts of interest, as outlined in Cochrane’s policy statement Yes No If yes, please give details. The Managing Editor will seek further information so that a decision can be made by the Cochrane Funding Arbiter. If the perceived conflict of interest of any author alters after signing this declaration, please contact for advice and to notify us of the change By completing this form, you accept responsibility for preparing the review in accordance with Cochrane policy. The Cochrane Consumers and Communication will support you in various ways to complete your review, including: development of search strategies, advice and assistance with RevMan software as needed, peer review of your protocol and review (and updates), and checking of your extracted data and
Individuals who are employed by a company that has a real or potential financial interest in the outcome of the Cochrane Review (including but not limited to drug companies or medical device manufacturers), or who hold or have applied for a patent related to the Cochrane Review are prohibited from being Cochrane Review authors. In most cases, employment would be characterised by the affiliation statement made by the author at the title registration, protocol, or review stage of the Cochrane Review. Any questions about what constitutes “employment by a company with a financial interest” should be referred to the Funding Arbiter. Authors who in the last three years have received financial support from commercial sponsors or sources who have a real or potential financial interest in the findings of the Cochrane Review, but who are not covered by the restriction above may need review by the Funding Arbiter panel. Such financial support may include remuneration from a consultancy, grants, fees, fellowships, support for sabbaticals, royalties, stocks from pharmaceutical companies, advisory board membership, or otherwise. In such cases, at the Funding Arbiter’s discretion, and only where a majority of the review authors and lead author have no relevant conflicts of interests, it may be possible for an author who has a declared interest as listed in the previous sentence to be a Cochrane Review author. Authors should declare potential conflicts even if they are confident that their judgement is not influenced (see ). Do you or your co-authors have any interests in this that could be perceived as conflicts of interest, as outlined in Cochrane’s policy statement Yes No If yes, please give details. The Managing Editor will seek further information so that a decision can be made by the Cochrane Funding Arbiter. If the perceived conflict of interest of any author alters after signing this declaration, please contact for advice and to notify us of the change By completing this form, you accept responsibility for preparing the review in accordance with Cochrane policy. The Cochrane Consumers and Communication will support you in various ways to complete your review, including: development of search strategies, advice and assistance with RevMan software as needed, peer review of your protocol and review (and updates), and checking of your extracted data and
cccg_title_proposal_form.docx